PubRank
Search
About
Rémy Poupot
Author PubWeight™ 19.82
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis.
Sci Transl Med
2011
1.69
2
Human gamma delta T cells induce dendritic cell maturation.
Clin Immunol
2002
1.29
3
FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways.
Blood
2004
1.27
4
Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.
Rheumatology (Oxford)
2012
1.23
5
A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.
Eur J Immunol
2009
1.02
6
PGE2 inhibits natural killer and gamma delta T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling.
Biochem Pharmacol
2010
1.01
7
The gene expression profile of phosphoantigen-specific human γδ T lymphocytes is a blend of αβ T-cell and NK-cell signatures.
Eur J Immunol
2011
0.99
8
Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses.
Int J Cancer
2010
0.91
9
Multiplication of human natural killer cells by nanosized phosphonate-capped dendrimers.
Angew Chem Int Ed Engl
2007
0.88
10
Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer.
J Leukoc Biol
2008
0.86
11
Pitfalls on the roadmap to gammadelta T cell-based cancer immunotherapies.
Immunol Lett
2009
0.85
12
Tailored control and optimisation of the number of phosphonic acid termini on phosphorus-containing dendrimers for the ex-vivo activation of human monocytes.
Chemistry
2008
0.85
13
Lenalidomide down regulates the production of interferon-gamma and the expression of inhibitory cytotoxic receptors of human Natural Killer cells.
Cell Immunol
2010
0.84
14
Design of phosphorylated dendritic architectures to promote human monocyte activation.
FASEB J
2006
0.84
15
Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission.
Am J Hematol
2010
0.82
16
Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells.
J Leukoc Biol
2008
0.81
17
Anti-inflammatory properties of dendrimers per se.
ScientificWorldJournal
2011
0.81
18
Dendrimers ended by non-symmetrical azadiphosphonate groups: synthesis and immunological properties.
Bioorg Med Chem Lett
2009
0.80
19
An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis.
Molecules
2013
0.79
20
Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent.
Arthritis Res Ther
2014
0.78
21
Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells.
Biomacromolecules
2015
0.78
22
Repeated intravenous injections in non-human primates demonstrate preclinical safety of an anti-inflammatory phosphorus-based dendrimer.
Nanotoxicology
2014
0.77